vimarsana.com

Latest Breaking News On - Americas committee - Page 17 : vimarsana.com

ACTRIMS 2023: Certain eye cells linked to MS-related changes | These cells may play key role in vision changes in MS, study finds

Certain eye cells specifically blood vessel and microglia cells exhibit high activity of genes that have been linked to MS, a study found.

San-diego
California
United-states
Johns-hopkins
Samantha-hao
Johns-hopkins-university
Americas-committee-for-treatment
Research-in-multiple-sclerosis
Americas-committee
Multiple-sclerosis
Single-cell-transcriptomics
Retinal-layer-thicknesses

ACTRIMS 2023: Documentary offers hope for Black MS community | In interview, MS advocates highlight 'huge' need for greater visibility

A new documentary, "MS in Black and African Americans," explores the experiences of Black patients in the U.S. living with multiple sclerosis.

Georgia
United-states
San-diego
California
San-diego-state-university
Americans
Sophia-woodson
Mitzi-joi-williams
Tyler-campbell
Americas-committee-for-treatment
Public-television
National-multiple-sclerosis-society

ACTRIMS 2023: Most patients on Briumvi show no MS activity after 6 months | Briumvi led to no MS activity in 80% of patients in ULTIMATE trials

More than 80% of MS patients on Briumvi in the ULTIMATE trials had no signs of disease activity after the first six months, data show.

Colorado
United-states
Sweden
California
San-diego
Washington
Swedish
Enrique-alvarez
Peiqing-qian
Swedish-neuroscience-institute
University-of-colorado
Americas-committee-for-treatment

ACTRIMS 2023: MS found to be less likely for HIV-positive people | HIV infection may protect against MS, especially in women: Study

People who are HIV-positive, including those given antiretroviral treatment, were found to be less likely to develop multiple sclerosis (MS).

Sweden
San-diego
California
United-states
Canada
United-kingdom
British
Canadian
Swedish
Elaine-kingwell
University-college-london
International-cohort

ACTRIMS 2023: CNM-Au8 bound for Phase 3 testing after positive data | Multiple Sclerosis News Today

The upcoming global Phase 3 clinical trial will test CNM-Au8's effect on MS disease progression that occurs independently of relapse activity.

San-diego
California
United-states
Dallas
Texas
Michael-hotchkin
Benjamin-greenberg
Clene-nanomedicine
Southwestern-medical-center
Americas-committee-for-treatment
Research-in-multiple-sclerosis
Multiple-sclerosis-news-today

vimarsana © 2020. All Rights Reserved.